Skip to main navigation Skip to search Skip to main content

Fungal-derived supplements in integrative oncology

  • Caroline Mohammed
  • , Ashley E. Aaroe
  • , Greg Buchold
  • , Daniel A.Pomeranz Krummel
  • , Paul Stamets
  • , Akanksha Sharma
  • , Lise Alschuler
  • , Soma Sengupta

Research output: Contribution to journalReview articlepeer-review

Abstract

There is significant interest in employing fungal-derived supplements to support cancer patients’ treatment and enhance their well-being. The use of these supplements is based on evidence from preclinical animal studies that highlight their ability to enhance immunomodulatory, neuroprotective, and antioxidant activities. Additionally, there are human clinical studies supporting these findings. While the varied studies suggest potential benefits of fungi, there is a paucity of examples of their utilization by healthcare professionals in the management of cancer care. In general, integrative oncology, which focuses on including natural approaches in patient care, is not commonly practiced. Herein, we provide examples of fungi contributing a positive impact on patients' well-being; this calls for greater investigation into the integration of such supplements in patient treatment. Our goal is to pique interest in the utilization of fungal-derived supplements, as part of an integrative medicine approach to patient care.

Original languageEnglish (US)
Pages (from-to)530-537
Number of pages8
JournalAmerican Journal of Medicine
Volume139
Issue number4
DOIs
StatePublished - Apr 2026

Keywords

  • Antioxidant
  • Fungal supplements
  • Fungi
  • Immunomodulation
  • Integrative medicine
  • Mushrooms
  • Neuroprotection

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Fungal-derived supplements in integrative oncology'. Together they form a unique fingerprint.

Cite this